APA সাইটেশন

Boyiadzis, M. M., Kirkwood, J. M., Marshall, J. L., Pritchard, C. C., Azad, N. S., & Gulley, J. L. (2018). Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease. J Immunother Cancer.

শিকাগো স্টাইলে সাইটেশন

Boyiadzis, Michael M., John M. Kirkwood, John L. Marshall, Colin C. Pritchard, Nilofer S. Azad, এবং James L. Gulley. "Significance and Implications of FDA Approval of Pembrolizumab for Biomarker-defined Disease." J Immunother Cancer 2018.

এমএলএ সাইটেশন

Boyiadzis, Michael M., et al. "Significance and Implications of FDA Approval of Pembrolizumab for Biomarker-defined Disease." J Immunother Cancer 2018.